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Available online 8 January 2016The majority of lung cancer cases result from complex interactions between smoking exposure, genetic suscep-
tibility and a person's immune response to chronic inﬂammation or lung remodelling. Epidemiological studies
conﬁrm that susceptibility to developing chronic obstructive pulmonary disease (COPD), especially emphysema,
is also closely linked to lung cancer susceptibility. Genetic epidemiology studies have consistently reported
associations between the chromosome 15q25 locus with lung cancer and COPD. In addition, studies show this
locus to be independently associated with cigarette consumption and nicotine addiction in a dose-response
manner, primarily at lower levels of cigarette consumption. Studies that measure both cigarette consumption
and lung function, together with extensive genotype analysis, will be needed to further unravel these complex
relationships.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Genetic susceptibilityIt is generally accepted that lung cancer results from a complex in-
teraction between smoking exposure, chronic lung disease and genetic
susceptibility (El Zein et al., 2012). Other factors found to be relevant in-
clude socioeconomic status, diet and ethnicity (Haiman et al., 2006). To
what degree, and through what mechanism, does gene variation confer
susceptibility to lung cancer remain to be elucidated. Furthermore, just
what extent ethnicity-speciﬁc genetic and cultural effects contribute to
lung cancer susceptibility also remains unclear. One feature of the ge-
netic studies to date is the consistent association between the chromo-
some 15q25 locus (chr15q25), encompassing subunits of the nicotine
acetylcholine receptor (CHRNA3 and 5 genes), and cigarette consump-
tion, lung function and lung cancer (David et al., 2016; Hung et al.,
2008; Young et al., 2008).
While the results by David and colleagues appear to support prior
studies, showing that the chr15q25 locus is independently associated
with cigarette consumption (and by inference nicotine addiction) and
lung cancer risk (David et al., 2016), there remain concerns about the
exact relevance of this association. Firstly, the association with this
locus encompasses as much as 4 potential candidate genes (CHRNA3,
CHRNA5, IREB2, PSMA4) including several functionally relevant SNP
variants found in a region where the degree of linkage disequilibrium
is still to be clariﬁed. The latter is particularly relevant in African
Americans (AA) where higher recombination rates can change theom.2016.01.002.
land 1344, New Zealand.
.
. This is an open access article underrelationship between the tested variants and the functional variants un-
derlying the phenotypic associations being reported (e.g. cigarette con-
sumption vs lung cancer). Second, there is no consideration for the
confounding or mediating effect that chronic obstructive pulmonary
disease (COPD)maybe having on the chr15q25 locus and its association
with lung cancer (Wang et al., 2010; Young et al., 2008). This is relevant
because AA have been reported to be at greater risk of COPD and greater
decline in lung function, compared to Caucasians (Hopkins et al., 2015).
Third, the greater risk of lung cancer reported in AA compared to Cauca-
sians is not seen in non-smokers and is lost in heavy smokers (Haiman
et al., 2006). This suggests a smoking by ethnicity interaction that is lost
in heavy smokers and the possibility that susceptibility effects conferred
by genetic variationmay be overwhelmed. This also suggests that mod-
erate smoking exposure creates an ethnic disparity in lung cancer risk
(or incidence) not seen in never smokers or heavy smokers (Haiman
et al., 2006; Hopkins et al., 2015). One of the most important features
of this increased risk of lung cancer among African Americans is the ap-
parent loss of the expected dose–response relationship between
smoking exposure and lung cancer (Hopkins et al., 2015). In contrast
to other ethnic groups, even light smoking exposure confers a high
risk of lung cancer in AA compared to Caucasians. These observations
suggest that while chr15q25 may partly determine cigarette consump-
tion in AA (David et al., 2016), something else such as the smoker's in-
herent response (or susceptibility) to aero-pollutant exposure may
underlie the greater disposition to lung cancer in this group. We pro-
pose that a greater susceptibility to COPDmay be relevant in this settingthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ogy studies like that reported by David and colleagues (David et al.,
2016), cannot clarify the role of unrecognized airﬂow limitation
(COPD). The study of David and colleagues also shows that the genetic
association with lung cancer in AA is only present in lighter smokers.
However, ethnic differences in lung cancer incidence in the US cannot
be explained by differences in smoking consumption, socioeconomic ef-
fects or diet (Haiman et al., 2006). We conclude that while AA have 1.5
fold higher lung cancer incidence than Caucasian smokers after adjust-
ment for other risk variables (Haiman et al., 2006; Hopkins et al.,
2015), it does not appear to be due to the non-genetic factors we tradi-
tionally associate with higher lung cancer risk (age, smoking exposure,
diet and socioeconomic factors). That the same observation is seen for
Hawaiians, argues against ethnic-speciﬁc differences in smoking prac-
tice (e.g. depth of inhalation or greater use of mentholated cigarettes)
(Hopkins et al., 2015).
In a multivariable analysis, Tockman and colleagues found that air-
ﬂow limitation (termed lung impairment) conferred a greater risk of
lung cancer (5 fold) relative to age and pack years (1.5–2.0 fold)
(Tockman et al., 1987). We suggest that there is much more to be
done to elucidate the relationship between smoking exposure, lung
function and immune modulation leading to pulmonary inﬂammatory
response to smoking. In this regard it is interesting that the chr15q25
locus association with lung cancer exists in non-smokers (Ji et al.,
2015). This certainly raises the possibility that factors attributable to
the chr15q locus, independent of smoking consumption (and nicotine
addiction), are relevant to lung cancer susceptibility which brings us
back to COPD. It has been shown that CHRNA3/5 genes are expressed
on lung epithelium and mediate the lung's inﬂammatory response to
smoking (Young et al., 2008). The ethnicity aspect is also relevant
here, as the chr15q25 locus is highly conserved andmay have important
functions relevant to mediating lung inﬂammation (Young et al., 2008),
where variation in immune response to pathogens is likely to result
from greater evolutionary selective pressures than to variation affecting
nicotine addiction (Paalani et al., 2011). Given COPD is thought to result
in part from an exaggerated innate immune response, as does lung can-
cer, it is very hard to see how susceptibility to airﬂow limitation can
continue to be overlooked in lung cancer studies (El Zein et al., 2012).
The take home message from the study by David and colleagues is
that the chr15q25 locus, previously linked to higher cigarettes con-
sumption and greater nicotine addiction, is similarly relevant insmokers with African American ancestry (Young et al., 2008). However,
while their ﬁndings support the hypothesis that the chr15q25 locus is
independently related to cigarette consumption and lung cancer in
African Americans, the exact contribution of genetic variation in this
chromosomal region to lung cancer susceptibility remains far from
clear.Disclosure
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